Rating History for Agomab Therapeutics (AGMB) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/3/2026 | Judah Frommer | New Coverage | Overweight (N/A) |
28.00 (N/A) |
16.02 (11.84) |
-26.09% | Details |
